Obesity Clinical Trial
Official title:
Dynamic Effect of Gastrointestinal Hormones on Cerebral Mechanisms Involved in Brain Perception of Food Pictures After Bariatric Surgery
| Verified date | June 2014 |
| Source | University of Lausanne |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Switzerland: University of Lausanne |
| Study type | Observational |
This is a cross-sectional study enrolling
- 11 weight-stable, formerly obese female patients 1-5 years after Roux-en-Y gastric
Bypass (RYGB)
- 11 age- and weight-matched female subjects
- 10 normal weight (Body Mass Index 19-25 kg/m2) subjects The following measurements will
be performed in each participants in basal conditions (after an overnight fast) and
after ingestion of a standard meal
- electroencephalographic recordings of visually evoked potential after presentation of
food- or non-food pictures
- plasma concentration of metabolites (glucose, fatty acids), glucoregulatory hormones
(insulin, glucagon), gastro-intestinal hormones (Gastric Inhibitory Polypeptide (GIP),
Glucagon-like Peptide-1 (GLP1), ghrelin,Cholecystokinin (CCK), and bile acids Aims of
this observational study are
- to evaluate the effects of RYGB on brain perception of food related visual stimulation
- to search for relationships between RYGB effects on brain responses and
gastro-intestinal hormone secretion
| Status | Completed |
| Enrollment | 31 |
| Est. completion date | March 2012 |
| Est. primary completion date | March 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 50 Years |
| Eligibility |
Inclusion Criteria: - good apparent health - gender: female - age 18-50 - non-smoker Exclusion Criteria: - diabetes or antidiabetic medication - consumption of more than 50g alcohol per week - vegetarian or any special diet |
Observational Model: Case Control, Time Perspective: Cross-Sectional
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | CHUV-clinical research center | Lausanne | VD |
| Lead Sponsor | Collaborator |
|---|---|
| University of Lausanne |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes of visually-evoked EEG potentials after ingestion of a meal | Recording and analysis of visual evoked potentials (VEPs) while patients categorize photographs of foods and non-food kitchen utensils | basal, 120 min postprandial and 240 postprandial | No |
| Secondary | changes in plasma triglyceride concentration after ingestion of a meal | Measurement of triglyceride concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) | basal, 90 min postprandial and 180 postprandial | No |
| Secondary | Changes in plasma glucoincretins (GLP1 and GIP) concentrations after ingestion of a meal | Measurement of GLP1 and GIP concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) | basal, 90 min postprandial and 180 postprandial | No |
| Secondary | Changes in plasma cholecystokinin concentrations after ingestion of a meal | Measurement of cholecystokinin concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) | basal, 90 min postprandial and 180 postprandial | No |
| Secondary | Changes in plasma bile acids concentrations after ingestion of a meal | Measurement of bile acids concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) | basal, 90 min postprandial and 180 postprandial | No |
| Secondary | changes in plasma glucoregulatory status after ingestion of a meal | Measurement of glucose, insulin, glucagon and non-esterified fatty acid concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) | basal, 90 min postprandial and 180 postprandial | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |